Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research Grade Ofatumumab | Login | Research Grade Ofatumumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Tocilizumab | Login | Research Grade Tocilizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Obinutuzumab | Login | Research Grade Obinutuzumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Blinatumomab | Login | Research Grade Blinatumomab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Siltuximab | Login | Research Grade Siltuximab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Vedolizumab | Login | Research Grade Vedolizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ocrelizumab | Login | Research Grade Ocrelizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Sarilumab | Login | Research Grade Sarilumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Fremanezumab | Login | Research Grade Fremanezumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Galcanezumab | Login | Research Grade Galcanezumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Brolucizumab | Login | Research Grade Brolucizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Teprotumumab | Login | Research Grade Teprotumumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Eptinezumab | Login | Research Grade Eptinezumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Sacituzumab | Login | Research Grade Sacituzumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Inebilizumab | Login | Research Grade Inebilizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Tafasitamab | Login | Research Grade Tafasitamab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Satralizumab | Login | Research Grade Satralizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Loncastuximab | Login | Research Grade Loncastuximab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Dafsolimab | Login | Research Grade Dafsolimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Divozilimab | Login | Research Grade Divozilimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Zuberitamab | Login | Research Grade Zuberitamab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Tusamitamab | Login | Research Grade Tusamitamab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Nofetumomab | Login | Research Grade Nofetumomab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ivonescimab | Login | Research Grade Ivonescimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Sotevtamab | Login | Research Grade Sotevtamab | ||||||||||||||||
|